- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01869660
Shared Decision Making for Patients With First-admission Schizophrenia
December 29, 2015 updated by: Yokohama City University
Shared Decision Making for Patients With First-admission Schizophrenia: a Randomized Controlled Trial
To determine whether shared decision making (SDM) intervention improves patient satisfaction in patients with first-admission schizophrenia compared with usual care.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
23
Phase
- Phase 2
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Shizuoka
-
Numazu, Shizuoka, Japan
- Numazu Chuou Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 65 years (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Admitted to an acute care psychiatric ward.
- Diagnosed with schizophrenia (ICD-10 codes: F20-F29)
- Aged 16 to 65 years old at admission
- No prior experience of psychiatric admission (first-admission)
Exclusion Criteria:
- Diagnosed with moderate to severe mental retardation
- Diagnosed with organic mental disorders (ICD10 codes: F00-F09)
- Having poor Japanese language skill
- Severe conceptual disorganization as measured by brief psychiatric rating scale of 5 or more.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Shared Decision Making
The present SDM intervention is based on principles derived from previous randomized controlled trials of SDMs.
SDM meetings comprise at least 4 weekly 20 minutes sessions.
Meetings have at least three professionals: a case manager (psychiatrists or nurses), a primary doctor, and a nurse/social worker.
The focus of the meeting is to empower patients to discuss their attitudes and preferences toward treatments.
|
The focus of the SDM is to empower patients to discuss their attitudes and preferences toward treatments.
|
|
No Intervention: Usual Care
Patients with no special program about decision making.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Patient satisfaction as measured by the Japanese version of the Client Satisfaction Questionnaire (CSQ-8)
Time Frame: Within 7days before the date of discharge
|
Within 7days before the date of discharge
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Attitude toward medication as measured by the Japanese version of the Drug Attitude Inventory (DAI-10)
Time Frame: Within 7days before the date of discharge
|
Within 7days before the date of discharge
|
|
Treatment continuation as measured by the rate of outpatient attendance during the 30 days
Time Frame: 6 months after discharge
|
6 months after discharge
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Yoshio Hirayasu, PhD, Department of Psychiatry, Yokohama City University School of Medical
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Ishii M, Okumura Y, Sugiyama N, Hasegawa H, Noda T, Hirayasu Y, Ito H. Feasibility and efficacy of shared decision making for first-admission schizophrenia: a randomized clinical trial. BMC Psychiatry. 2017 Feb 6;17(1):52. doi: 10.1186/s12888-017-1218-1.
- Ishii M, Okumura Y, Sugiyama N, Hasegawa H, Noda T, Hirayasu Y, Ito H. Efficacy of shared decision making on treatment satisfaction for patients with first-admission schizophrenia: study protocol for a randomised controlled trial. BMC Psychiatry. 2014 Apr 14;14:111. doi: 10.1186/1471-244X-14-111.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2013
Primary Completion (Actual)
April 1, 2015
Study Completion (Actual)
October 1, 2015
Study Registration Dates
First Submitted
May 27, 2013
First Submitted That Met QC Criteria
May 30, 2013
First Posted (Estimate)
June 5, 2013
Study Record Updates
Last Update Posted (Estimate)
December 30, 2015
Last Update Submitted That Met QC Criteria
December 29, 2015
Last Verified
August 1, 2015
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- SDMS-S
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenia
-
First Affiliated Hospital of Fujian Medical UniversityNot yet recruiting
-
Fundació Institut de Recerca de l'Hospital de la...Recruiting
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Organon and CoCompletedSchizophrenia, Paranoid | Schizophrenia, Disorganized | Schizophrenia, Undifferentiated
-
Newron Pharmaceuticals SPARecruitingTreatment-resistant SchizophreniaUnited States, India
-
All India Institute of Medical Sciences, BhubaneswarCompletedTreatment Resistant SchizophreniaIndia
-
Bradley LegaRecruiting
-
Central Institute of Mental Health, MannheimRecruitingSchizophrenia | Treatment Resistant SchizophreniaGermany
-
Shanghai Zhongze Therapeutics Co., Ltd.Yale UniversityNot yet recruiting
-
Ole Köhler-ForsbergAarhus University HospitalRecruiting
Clinical Trials on Shared Decision Making
-
The University of Texas Health Science Center,...TerminatedPregnancy Related | Elective InductionUnited States
-
Shalvata Mental Health CenterUnknownShared Decision Making With PatientsIsrael
-
Christiana Care Health ServicesNational Institute of General Medical Sciences (NIGMS); Thomas Jefferson University and other collaboratorsCompleted
-
UMC UtrechtCompletedShared Decision Making Between Patients and GPs in the Treatment of Type 2 Diabetes in Primary Care.Type 2 Diabetes MellitusNetherlands
-
National Heart, Lung, and Blood Institute (NHLBI)Completed
-
SingHealth PolyclinicsSingapore General HospitalCompletedPatient Engagement | Patient PreferenceSingapore
-
Taipei Medical University Shuang Ho HospitalCompleted
-
University Hospitals, LeicesterCompletedPulmonary Disease, Chronic ObstructiveUnited Kingdom
-
Hospital for Special Surgery, New YorkJohns Hopkins University; Baylor College of Medicine; University of Pennsylvania and other collaboratorsTerminatedKnee OsteoarthritisUnited States
-
University of MichiganCompleted